NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
35.44
-0.30 (-0.84%)
At close: May 22, 2026, 4:00 PM EDT
36.60
+1.16 (3.27%)
After-hours: May 22, 2026, 4:58 PM EDT
NAMS Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, NAMS stock has a consensus rating of "Strong Buy" and an average price target of $50.04. The average 1-year stock price forecast is 41.20% higher than the current stock price, while the lowest is $37.48 (+5.76%) and the highest is $59.41 (+67.64%).
Price Target: $50.04 (+41.20%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 19, 2026.
Analyst Ratings
The average analyst rating for NAMS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 5 | 5 | 5 | 5 |
| Buy | 4 | 4 | 3 | 3 | 3 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 9 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $41 → $45 | Strong Buy | Maintains | $41 → $45 | +26.98% | Feb 19, 2026 |
| Needham | Needham | Strong Buy Maintains $46 → $48 | Strong Buy | Maintains | $46 → $48 | +35.44% | Feb 18, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $44 → $47 | Buy | Maintains | $44 → $47 | +32.62% | Jan 21, 2026 |
| Stifel | Stifel | Strong Buy Maintains $44 → $50 | Strong Buy | Maintains | $44 → $50 | +41.08% | Dec 16, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $30 → $37 | Hold | Maintains | $30 → $37 | +4.40% | Dec 2, 2025 |
Financial Forecast
Revenue This Year
29.99M
from 22.50M
Increased by 33.25%
Revenue Next Year
173.82M
from 29.99M
Increased by 479.69%
EPS This Year
-1.86
from -1.72
EPS Next Year
-1.58
from -1.86
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 63.0M | 631.5M | ||||||
| Avg | 30.0M | 173.8M | ||||||
| Low | n/a | 23.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 180.0% | 2,006.0% | ||||||
| Avg | 33.2% | 479.7% | ||||||
| Low | - | -21.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.48 | 2.48 | ||||||
| Avg | -1.86 | -1.58 | ||||||
| Low | -2.12 | -3.14 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.